Impaired insulin action in the human brain: causes and metabolic consequences (Q38605675)

4 September 2017

Impaired insulin action in the human brain: causes and metabolic consequences (English)

1 reference

4 September 2017

Martin Heni

1

0 references

Hans-Ulrich Häring

series ordinal

5

object named as

Hans-Ulrich Häring

1 reference

4 September 2017

3

Hubert Preissl

1 reference

4 September 2017

4

Andreas Fritsche

1 reference

4 September 2017

2

Stephanie Kullmann

1 reference

4 September 2017

13 October 2015

1 reference

Nature Reviews Endocrinology

4 September 2017

1 reference

4 September 2017

11

1 reference

4 September 2017

701-711

1 reference

4 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2015.173

4 September 2017

0 references

cites work

Insulin receptors are widely distributed in the central nervous system of the rat

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Role of brain insulin receptor in control of body weight and reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin action in brain regulates systemic metabolism and brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The many faces of insulin-like peptide signalling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Effect of insulin on the brain activity obtained during visual and memory tasks in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin affects the neuronal response in the medial temporal lobe in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin reduces the BOLD response but is without effect on the VEP during presentation of a visual task in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Sniffing neuropeptides: a transnasal approach to the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin modulation of magnetoencephalographic resting state dynamics in lean and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Central nervous system effects of intranasally administered insulin during euglycemia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The insulin-mediated modulation of visually evoked magnetic fields is reduced in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal delivery of insulin via the olfactory nerve pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal Neuropeptide Administration To Target the Human Brain in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Identification of insulin in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The source of cerebral insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Cerebrospinal fluid insulin during non-neurological surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Human blood-brain barrier insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin regulates brain function, but how does it get there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin action in the human brain: evidence from neuroimaging studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Altered hypothalamic function in response to glucose ingestion in obese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Mapping glucose-mediated gut-to-brain signalling pathways in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Differential effect of glucose ingestion on the neural processing of food stimuli in lean and overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Functional MRI of human hypothalamic responses following glucose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Short-term caloric restriction normalizes hypothalamic neuronal responsiveness to glucose ingestion in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Glucose ingestion fails to inhibit hypothalamic neuronal activity in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin modulates intrinsic reward and prefrontal circuitry of the human brain in lean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin modulates food-related activity in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

(Still) longing for food: insulin reactivity modulates response to food pictures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Memory formation and long-term retention in humans and animals: convergence towards a transformation account of hippocampal-neocortical interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Improving influence of insulin on cognitive functions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin improves memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin improves memory in humans: superiority of insulin aspart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin and hippocampus activation in response to images of high-calorie food in normal weight and obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Acute, short-term hyperinsulinemia increases olfactory threshold in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin reduces olfactory sensitivity in normosmic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Associations between postprandial insulin and blood glucose responses, appetite sensations and energy intake in normal weight and overweight individuals: a meta-analysis of test meal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Brain insulin controls adipose tissue lipolysis and lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Circulating insulin stimulates fatty acid retention in white adipose tissue via KATP channel activation in the central nervous system only in insulin-sensitive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Response to Comment on Heni et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 2014;63:4083-4088.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Risk of postprandial insulin resistance: the liver/vagus rapport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

A brain-liver circuit regulates glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin's effect on the liver: "direct or indirect?" continues to be the question

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Activation of K(ATP) channels suppresses glucose production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Is brain insulin action relevant to the control of plasma glucose in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Central nervous insulin administration does not potentiate the acute glucoregulatory impact of concurrent mild hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Gut-brain mechanisms controlling glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Obese men respond to cognitive but not to catabolic brain insulin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Central insulin signaling modulates hypothalamus-pituitary-adrenal axis responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin sensitivity of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The obese brain: association of body mass index and insulin sensitivity with resting state network functional connectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Cerebrocortical beta activity in overweight humans responds to insulin detemir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Effects of insulin on brain glucose metabolism in impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin effects on beta and theta activity in the human brain are differentially affected by ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Effect of a diabetic environment in utero on predisposition to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Hypothalamic alterations in fetuses of high fat diet-fed obese female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Inflammatory response of human coronary artery endothelial cells to saturated long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Toll-like receptors: linking inflammation to metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Selective insulin and leptin resistance in metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Leptin affects insulin action in astrocytes and impairs insulin-mediated physical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Leptin regulates striatal regions and human eating behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Leptin therapy in a congenital leptin-deficient patient leads to acute and long-term changes in homeostatic, reward, and food-related brain areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Cooperation between brain and islet in glucose homeostasis and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Variation in FTO contributes to childhood obesity and severe adult obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Variation in the FTO gene influences food intake but not energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Variation in the obesity risk gene FTO determines the postprandial cerebral processing of food stimuli in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

An Obesity Risk SNP (rs17782313) near the MC4R Gene Is Associated with Cerebrocortical Insulin Resistance in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Central nervous system control of food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

A frameshift mutation in MC4R associated with dominantly inherited human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

A frameshift mutation in human MC4R is associated with a dominant form of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Neural correlates of stress- and food cue-induced food craving in obesity: association with insulin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Brain metabolic dysfunction at the core of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Alzheimer disease: Insulin resistance and AD--extending the translational path.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Tissue selectivity of insulin detemir action in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Reversal of diet-induced obesity increases insulin transport into cerebrospinal fluid and restores sensitivity to the anorexic action of central insulin in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Anorexigenic effects of GLP-1 and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

A (3H)2-Deoxyglucose Method for Comparing Rates of Glucose Metabolism and Insulin Responses Among Rat Tissues In Vivo: Validation of the Model and the Absence of an Insulin Effect on Brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Low cerebrospinal fluid insulin levels in obese humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin and Alzheimer's disease: untangling the web.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Intranasal insulin reduces body fat in men but not in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Insulin regulation of lipolysis in nondiabetic and IDDM subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Hypothalamic insulin signaling is required for inhibition of glucose production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Unconditioned and conditioned effects of intranasally administered insulin vs placebo in healthy men: a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Long-term stabilization effects of leptin on brain functions in a leptin-deficient patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

Central insulin action regulates peripheral glucose and fat metabolism in mice

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26460339

12 December 2020

inferred from PubMed ID database lookup

Role of non-neuronal cells in body weight and appetite control

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26460339

12 December 2020

inferred from PubMed ID database lookup

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.173

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NRENDO.2015.173

1 reference

PubMed ID

26460339

Dimensions Publication ID

4 September 2017

1004381579

0 references

Fatcat ID

release_7dviffe4erdhnex2u66ndddgbq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7dviffe4erdhnex2u66ndddgbq

24 November 2022

mapped directly with Wikidata item

PubMed ID

26460339

1 reference

PubMed ID

26460339